COLL vs ESS · P/E 17, rev $181.9M vs P/E 31, rev $1.89B
Collegium Pharmaceutical Inc (COLL) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the COLL and ESS stock pages for the full models.
Not investment advice.